NEW YORK--(BUSINESS WIRE)--Target ALS Foundation, a collaborative research consortium focused on discovering treatments and a cure for ALS, has received a $5 million donation from Biogen that will fund critical ALS research across a network of academic laboratories. The Biogen donation helps establish the Industry Fund for ALS Research and launches a challenge to raise $20 million for Target ALS from other industry donors to support precompetitive research of value to the whole ALS community. Biogen has further committed to matching 50 percent of contributions by biotech and pharmaceutical companies to the fund through 2018. Companies contributing more than $1 million will be given the title of Founding Member.
